SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-062688
Filing Date
2020-12-10
Accepted
2020-12-10 16:05:22
Documents
2
Period of Report
2020-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4246
2 POA DOCUMENT poa.txt EX-24.4_949370 3523
  Complete submission text file 0001209191-20-062688.txt   9484
Mailing Address C/O LA JOLLA PHARMACEUTICAL COMPANY LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address
Johnson Laura L. (Reporting) CIK: 0001589362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38318 | Film No.: 201380601

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Issuer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations